HomeCompareMPLN vs MRK

MPLN vs MRK: Dividend Comparison 2026

MPLN yields 8.64% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $21.3K in total portfolio value· pulled ahead in Year 6
10 years
MPLN
MPLN
● Live price
8.64%
Share price
$23.15
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$35.4K
Annual income
$1,490.69
Full MPLN calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — MPLN vs MRK

📍 MRK pulled ahead of the other in Year 6

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMPLNMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MPLN + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MPLN pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MPLN
Annual income on $10K today (after 15% tax)
$734.34/yr
After 10yr DRIP, annual income (after tax)
$1,267.09/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $7,061.32/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MPLN + MRK for your $10,000?

MPLN: 50%MRK: 50%
100% MRK50/50100% MPLN
Portfolio after 10yr
$46.1K
Annual income
$5,644.41/yr
Blended yield
12.24%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MPLN
Analyst Ratings
2
Buy
4
Hold
Consensus: Hold
Price Target
$10.00
-56.8% upside vs current
Range: $10.00 — $10.00
Altman Z
-0.4
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MPLN buys
0
MRK buys
0
No recent congressional trades found for MPLN or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMPLNMRK
Forward yield8.64%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$35.4K$56.8K
Annual income after 10y$1,490.69$9,798.13
Total dividends collected$11.8K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$10.00$128.54

Year-by-year: MPLN vs MRK ($10,000, DRIP)

YearMPLN PortfolioMPLN Income/yrMRK PortfolioMRK Income/yrGap
1$11,564$863.93$11,206$366.19+$358.00MPLN
2$13,307$933.69$12,650$502.35+$657.00MPLN
3$15,243$1,004.14$14,407$694.19+$836.00MPLN
4$17,385$1,074.96$16,585$967.82+$800.00MPLN
5$19,747$1,145.80$19,342$1,363.89+$405.00MPLN
6← crossover$22,346$1,216.38$22,913$1,947.19$567.00MRK
7$25,197$1,286.41$27,662$2,823.89$2.5KMRK
8$28,316$1,355.62$34,159$4,173.35$5.8KMRK
9$31,722$1,423.78$43,337$6,308.80$11.6KMRK
10$35,433$1,490.69$56,776$9,798.13$21.3KMRK

MPLN vs MRK: Complete Analysis 2026

MPLNStock

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.

Full MPLN Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this MPLN vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MPLN vs SCHDMPLN vs JEPIMPLN vs OMPLN vs KOMPLN vs MAINMPLN vs JNJMPLN vs ABBVMPLN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.